• aifa grants announced 2016
  • Information for health professionals
  • Online anaphylaxis training
  • 5 things to question
ASCIA News

  • Thunderstorm asthma epidemic
    Dec 2, 2016:  The recent thunderstorm asthma epidemic in Melbourne and its tragic consequences highlight the need for more research and education in this area. For information on thunderstorm asthma go to www.allergy.org.au/patients/asthma-and-allergy/thunderstorm-asthma  Further information on thunderstorm asthma will be ...
  • ASCIA highlights 2016 and plans for 2017
    Nov 28, 2016:  A summary of highlights 2016 and plans for 2017 is now available at www.allergy.org.au/about-ascia/highlights. Thank you to ASCIA members and supporters for your greatly appreciated contributions throughout 2016. We look forward to continuing to work with you in 2017 on a wide range of projects.
  • Allergy and Immunology Foundation of Australasia (AIFA) Research Grants
    Nov 16, 2016:  The AIFA Board is pleased to announce two $10,000 grants, one supporting research into Jack Jumper Ant immunotherapy and the second that will improve development of a drug for allergy. For information about these grants go to www.allergyimmunology.org.au/news/99-aifa-announces-2016-research-grants Over the past 3 yea...
  • AusPollen Apps for people with allergic rhinitis (hay fever) and allergic asthma
    Nov 8, 2016:  Local AusPollen Apps provide information on daily levels of pollen in the air and are currently available for Brisbane, Canberra, Melbourne and Sydney at www.pollenforecast.com.au by downloading the free App for iTunes or Google Play, and through Twitter or Facebook. Completion of a short (~5 minute) online questio...
  • National Allergy Strategy - KABAM survey
    Nov 3, 2016:  THANK YOU to all who participated in the National Allergy Strategy survey for teens and young adults (KABAM survey). The response has been overwhelming and we look forward to reviewing the information to ensure we develop suitable resources for 12-24 year olds with severe allergy. Stay tuned for updates on resource devel...
  • ASCIA 2016 Conference Report
    Sep 21, 2016:  The ASCIA 2016 conference provided more than 600 delegates with a unique opportunity to hear from 6 international experts and more than 30 local experts on a wide range of areas in allergy and clinical immunology. The conference also included 79 posters, 48 poster presentations and 16 clinical grand rounds presentations...
  • AIFA seed funding leads to NHMRC grant
    Aug 23, 2016:  We are proud to announce that the AusPollen project has been awarded $626,442 in the latest round of NHMRC Partnership Project grants with a further $653,129 in partner organisation in kind and cash support. AusPollen, the Australian Pollen Allergen Partnership, will build, implement and evaluate the first standardised ...
  • Updated ASCIA Action Plans for Anaphylaxis and Allergic Reactions
    Aug 10, 2016:  ASCIA has released updated Action Plans for Anaphylaxis and Allergic Reactions on its website: www.allergy.org.au/health-professionals/anaphylaxis-resources/ascia-action-plan-for-anaphylaxis The main changes are an increased emphasis of key messages, inclusion of images to show how to position a person with anaphylaxi...
  • ASCIA releases guidelines for infant feeding and allergy prevention
    May 18, 2016: ASCIA Guidelines for infant feeding and allergy prevention and information on how to introduce solid foods to infants have been released on the ASCIA website: www.allergy.org.au/patients/allergy-prevention  These guidelines provide parents and health professionals with advice and recommendations relevant to...
  • Federal Government announces funding of $500k for National Allergy Strategy implementation
    May 16, 2016:  It is with great pleasure that we confirm that the federal government's funding of $500k for National Allergy Strategy implementation was announced at the launch of Food Allergy Week in Sydney on 16 May 2016, by the Minister for Health, the Hon Sussan Ley MP. The National Allergy Strategy was launched in...
  • Changes to adrenaline autoinjector labels
    Apr 19 2016:  In Australia, adrenaline is the approved name of the ingredient in autoinjector devices used for the emergency treatment of anaphylaxis. Currently, the only available autoinjector to treat anaphylaxis in Australia and New Zealand is supplied under the brand name EpiPenĀ®. In some countries, including the USA, adrenaline i...
ASCIA is a WAO member society

ASCIA is a WAO member society
Follow ASCIA

ASCIA on facebookASCIA on TwitterASCIA on YouTube

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.